Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05631119 · ClinicalTrials.gov registry record
Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes
A clinical trial, sponsored by Sanguine Biosciences.
- Completed
- Registry status
- 40
- Enrollment target
NCT05631119 is a clinical trial that has completed, run by Sanguine Biosciences. The registered enrollment target is 40 participants.
The verdict
NCT05631119 has completed, sponsored by Sanguine Biosciences.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic or diabetic kidney disease will lay the groundwork for an extensive network of biosample access and linked datasets that will provide an invaluable resource for translational research.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-12-15 |
| Est. Completion | 2023-08-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05631119
The ClinicalTrials.gov registry entry for NCT05631119 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanguine Biosciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05631119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05631119 about?
NCT05631119 is a clinical study titled "Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes". The Investigators will generate a repository of human biosamples across therapeutic areas that will be used to identify disease-associated biomarkers and potential targets with immune and multi-omics profiling. This sample collection and analysis from people living with type 2 diabetes, or chronic o...
What is the current status of trial NCT05631119?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2022-12-15. Estimated completion is 2023-08-23.
Who is sponsoring clinical trial NCT05631119?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.